Skip to main content

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  212.37
+2.60 (1.24%)
AAPL  261.72
+5.80 (2.27%)
AMD  220.47
+2.97 (1.37%)
BAC  50.01
+0.63 (1.28%)
GOOG  296.67
+2.21 (0.75%)
META  576.32
+1.86 (0.32%)
MSFT  372.65
-0.81 (-0.22%)
NVDA  176.75
-0.63 (-0.36%)
ORCL  144.76
-1.62 (-1.11%)
TSLA  360.08
-0.51 (-0.14%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.